Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and others cancers

Nilanjan Chatterjee, Patricia Hartge, James R Cerhan, Wendy Cozen, Scott Davis, Naoko Ishibe, Joanne Colt, Lynn Goldin, Richard K. Severson

Research output: Contribution to journalArticle

121 Citations (Scopus)

Abstract

Background: An elevated risk of developing non-Hodgkin's lymphoma (NHL) has been associated with a family history of NHL and several other malignancies, but the magnitude of risks and mechanisms are uncertain. Methods: We used self-reported family history data from a recent multicenter U.S.-based case-control studies of NHL to evaluate familial aggregation of NHL with various hematolymphoproliferative and other cancers. Estimates of familial aggregation were obtained as hazard ratios (HR) that compare incidence of different cancers in first-degree relatives of NHL cases with that in the first-degree relatives of NHL controls. Limitations of the study included low participation rates (76% for cases and 52% for controls) and potential differential accuracy of recall. Results: Risk of NHL was elevated in relatives of NHL cases [HR, 2.9; 95% confidence interval (95% CI), 0.95-8.53]; the aggregation seems to be stronger for siblings (HR, 7.6; 95% CI, 0.98-58.8) and for male relatives (HR, 6.2; 95% CI, 0.77-50.0). Risk of Hodgkin's lymphoma seems to be also elevated among relatives of early-onset (<50 years) NHL cases (HR, 3.2; 95% CI, 0.88-11.6). Evaluation of family history of other cancers provided modest evidence for an increased risk of melanoma of the skin (HR, 2.9; 95% CI, 1.08-7.75), pancreatic cancer (HR, 2.1; 95% CI, 0.96-4.43), stomach cancer (HR, 1.8; 95% CI, 0.91-3.63), and prostate cancer (HR, 1.3; 95% CI, 0.87-1.99). Conclusions: These results are consistent with previous findings of familial aggregation of NHL, Hodgkin's lymphoma, and a few other cancers. The pattern of male-specific and sibling-specific familial aggregation of NHL we observed, if confirmed, may shed new light on the possible mechanisms that underlie familial aggregation of the disease.

Original languageEnglish (US)
Pages (from-to)1415-1421
Number of pages7
JournalCancer Epidemiology Biomarkers and Prevention
Volume13
Issue number9
StatePublished - Sep 2004

Fingerprint

Non-Hodgkin's Lymphoma
Confidence Intervals
Neoplasms
Hodgkin Disease
Pancreatic Neoplasms
Stomach Neoplasms
Case-Control Studies
Melanoma
Prostatic Neoplasms
Skin
Incidence

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Chatterjee, N., Hartge, P., Cerhan, J. R., Cozen, W., Davis, S., Ishibe, N., ... Severson, R. K. (2004). Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and others cancers. Cancer Epidemiology Biomarkers and Prevention, 13(9), 1415-1421.

Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and others cancers. / Chatterjee, Nilanjan; Hartge, Patricia; Cerhan, James R; Cozen, Wendy; Davis, Scott; Ishibe, Naoko; Colt, Joanne; Goldin, Lynn; Severson, Richard K.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 13, No. 9, 09.2004, p. 1415-1421.

Research output: Contribution to journalArticle

Chatterjee, N, Hartge, P, Cerhan, JR, Cozen, W, Davis, S, Ishibe, N, Colt, J, Goldin, L & Severson, RK 2004, 'Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and others cancers', Cancer Epidemiology Biomarkers and Prevention, vol. 13, no. 9, pp. 1415-1421.
Chatterjee, Nilanjan ; Hartge, Patricia ; Cerhan, James R ; Cozen, Wendy ; Davis, Scott ; Ishibe, Naoko ; Colt, Joanne ; Goldin, Lynn ; Severson, Richard K. / Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and others cancers. In: Cancer Epidemiology Biomarkers and Prevention. 2004 ; Vol. 13, No. 9. pp. 1415-1421.
@article{23ec9f59486a4858a8e4d70a607b7a54,
title = "Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and others cancers",
abstract = "Background: An elevated risk of developing non-Hodgkin's lymphoma (NHL) has been associated with a family history of NHL and several other malignancies, but the magnitude of risks and mechanisms are uncertain. Methods: We used self-reported family history data from a recent multicenter U.S.-based case-control studies of NHL to evaluate familial aggregation of NHL with various hematolymphoproliferative and other cancers. Estimates of familial aggregation were obtained as hazard ratios (HR) that compare incidence of different cancers in first-degree relatives of NHL cases with that in the first-degree relatives of NHL controls. Limitations of the study included low participation rates (76{\%} for cases and 52{\%} for controls) and potential differential accuracy of recall. Results: Risk of NHL was elevated in relatives of NHL cases [HR, 2.9; 95{\%} confidence interval (95{\%} CI), 0.95-8.53]; the aggregation seems to be stronger for siblings (HR, 7.6; 95{\%} CI, 0.98-58.8) and for male relatives (HR, 6.2; 95{\%} CI, 0.77-50.0). Risk of Hodgkin's lymphoma seems to be also elevated among relatives of early-onset (<50 years) NHL cases (HR, 3.2; 95{\%} CI, 0.88-11.6). Evaluation of family history of other cancers provided modest evidence for an increased risk of melanoma of the skin (HR, 2.9; 95{\%} CI, 1.08-7.75), pancreatic cancer (HR, 2.1; 95{\%} CI, 0.96-4.43), stomach cancer (HR, 1.8; 95{\%} CI, 0.91-3.63), and prostate cancer (HR, 1.3; 95{\%} CI, 0.87-1.99). Conclusions: These results are consistent with previous findings of familial aggregation of NHL, Hodgkin's lymphoma, and a few other cancers. The pattern of male-specific and sibling-specific familial aggregation of NHL we observed, if confirmed, may shed new light on the possible mechanisms that underlie familial aggregation of the disease.",
author = "Nilanjan Chatterjee and Patricia Hartge and Cerhan, {James R} and Wendy Cozen and Scott Davis and Naoko Ishibe and Joanne Colt and Lynn Goldin and Severson, {Richard K.}",
year = "2004",
month = "9",
language = "English (US)",
volume = "13",
pages = "1415--1421",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

TY - JOUR

T1 - Risk of non-Hodgkin's lymphoma and family history of lymphatic, hematologic, and others cancers

AU - Chatterjee, Nilanjan

AU - Hartge, Patricia

AU - Cerhan, James R

AU - Cozen, Wendy

AU - Davis, Scott

AU - Ishibe, Naoko

AU - Colt, Joanne

AU - Goldin, Lynn

AU - Severson, Richard K.

PY - 2004/9

Y1 - 2004/9

N2 - Background: An elevated risk of developing non-Hodgkin's lymphoma (NHL) has been associated with a family history of NHL and several other malignancies, but the magnitude of risks and mechanisms are uncertain. Methods: We used self-reported family history data from a recent multicenter U.S.-based case-control studies of NHL to evaluate familial aggregation of NHL with various hematolymphoproliferative and other cancers. Estimates of familial aggregation were obtained as hazard ratios (HR) that compare incidence of different cancers in first-degree relatives of NHL cases with that in the first-degree relatives of NHL controls. Limitations of the study included low participation rates (76% for cases and 52% for controls) and potential differential accuracy of recall. Results: Risk of NHL was elevated in relatives of NHL cases [HR, 2.9; 95% confidence interval (95% CI), 0.95-8.53]; the aggregation seems to be stronger for siblings (HR, 7.6; 95% CI, 0.98-58.8) and for male relatives (HR, 6.2; 95% CI, 0.77-50.0). Risk of Hodgkin's lymphoma seems to be also elevated among relatives of early-onset (<50 years) NHL cases (HR, 3.2; 95% CI, 0.88-11.6). Evaluation of family history of other cancers provided modest evidence for an increased risk of melanoma of the skin (HR, 2.9; 95% CI, 1.08-7.75), pancreatic cancer (HR, 2.1; 95% CI, 0.96-4.43), stomach cancer (HR, 1.8; 95% CI, 0.91-3.63), and prostate cancer (HR, 1.3; 95% CI, 0.87-1.99). Conclusions: These results are consistent with previous findings of familial aggregation of NHL, Hodgkin's lymphoma, and a few other cancers. The pattern of male-specific and sibling-specific familial aggregation of NHL we observed, if confirmed, may shed new light on the possible mechanisms that underlie familial aggregation of the disease.

AB - Background: An elevated risk of developing non-Hodgkin's lymphoma (NHL) has been associated with a family history of NHL and several other malignancies, but the magnitude of risks and mechanisms are uncertain. Methods: We used self-reported family history data from a recent multicenter U.S.-based case-control studies of NHL to evaluate familial aggregation of NHL with various hematolymphoproliferative and other cancers. Estimates of familial aggregation were obtained as hazard ratios (HR) that compare incidence of different cancers in first-degree relatives of NHL cases with that in the first-degree relatives of NHL controls. Limitations of the study included low participation rates (76% for cases and 52% for controls) and potential differential accuracy of recall. Results: Risk of NHL was elevated in relatives of NHL cases [HR, 2.9; 95% confidence interval (95% CI), 0.95-8.53]; the aggregation seems to be stronger for siblings (HR, 7.6; 95% CI, 0.98-58.8) and for male relatives (HR, 6.2; 95% CI, 0.77-50.0). Risk of Hodgkin's lymphoma seems to be also elevated among relatives of early-onset (<50 years) NHL cases (HR, 3.2; 95% CI, 0.88-11.6). Evaluation of family history of other cancers provided modest evidence for an increased risk of melanoma of the skin (HR, 2.9; 95% CI, 1.08-7.75), pancreatic cancer (HR, 2.1; 95% CI, 0.96-4.43), stomach cancer (HR, 1.8; 95% CI, 0.91-3.63), and prostate cancer (HR, 1.3; 95% CI, 0.87-1.99). Conclusions: These results are consistent with previous findings of familial aggregation of NHL, Hodgkin's lymphoma, and a few other cancers. The pattern of male-specific and sibling-specific familial aggregation of NHL we observed, if confirmed, may shed new light on the possible mechanisms that underlie familial aggregation of the disease.

UR - http://www.scopus.com/inward/record.url?scp=4444250628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4444250628&partnerID=8YFLogxK

M3 - Article

C2 - 15342441

AN - SCOPUS:4444250628

VL - 13

SP - 1415

EP - 1421

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 9

ER -